Nuveen’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $759M | Sell |
1,513,180
-133,809
| -8% | -$64.2M | 0.18% | 100 |
|
|
2026
Q1 | $810M | Sell |
1,646,989
-500,307
| -23% | -$272M | 0.22% | 88 |
|
|
2025
Q4 | $1.24B | Buy |
2,147,296
+846,111
| +65% | +$478M | 0.33% | 60 |
|
|
2025
Q3 | $631M | Buy |
1,301,185
+129,970
| +11% | +$60.5M | 0.17% | 108 |
|
|
2025
Q2 | $475M | Buy |
1,171,215
+101,359
| +9% | +$42.4M | 0.13% | 138 |
|
|
2025
Q1 | $532M | Sell |
1,069,856
-63,829
| -6% | -$34.6M | 0.16% | 120 |
|
|
2024
Q4 | $590M | Sell |
1,133,685
-105,693
| -9% | -$58.1M | 0.17% | 106 |
|
|
2024
Q3 | $767M | Sell |
1,239,378
-45,616
| -4% | -$27M | 0.22% | 88 |
|
|
2024
Q2 | $711M | Buy |
1,284,994
+22,198
| +2% | +$12.7M | 0.21% | 92 |
|
|
2024
Q1 | $734M | Sell |
1,262,796
-4,612
| -0.4% | -$2.59M | 0.22% | 88 |
|
|
2023
Q4 | $673M | Sell |
1,267,408
-46,022
| -4% | -$22.3M | 0.22% | 93 |
|
|
2023
Q3 | $665M | Sell |
1,313,430
-17,241
| -1% | -$9.19M | 0.23% | 95 |
|
|
2023
Q2 | $694M | Sell |
1,330,671
-8,617
| -0.6% | -$4.65M | 0.24% | 88 |
|
|
2023
Q1 | $772M | Buy |
1,339,288
+56,734
| +4% | +$32M | 0.29% | 81 |
|
|
2022
Q4 | $706M | Sell |
1,282,554
-258,594
| -17% | -$137M | 0.27% | 87 |
|
|
2022
Q3 | $782M | Sell |
1,541,148
-34,374
| -2% | -$19.2M | 0.32% | 69 |
|
|
2022
Q2 | $856M | Sell |
1,575,522
-39,039
| -2% | -$21.5M | 0.33% | 66 |
|
|
2022
Q1 | $951M | Sell |
1,614,561
-7,346
| -0.5% | -$4.22M | 0.31% | 65 |
|
|
2021
Q4 | $1.08B | Sell |
1,621,907
-7,795
| -0.5% | -$4.87M | 0.32% | 61 |
|
|
2021
Q3 | $931M | Sell |
1,629,702
-168,635
| -9% | -$92.6M | 0.29% | 73 |
|
|
2021
Q2 | $907M | Sell |
1,798,337
-243,551
| -12% | -$115M | 0.27% | 80 |
|
|
2021
Q1 | $932M | Sell |
2,041,888
-2,889
| -0.1% | -$1.38M | 0.3% | 66 |
|
|
2020
Q4 | $952M | Buy |
2,044,777
+152,071
| +8% | +$71.3M | 0.32% | 63 |
|
|
2020
Q3 | $836M | Buy |
1,892,706
+37,545
| +2% | +$15.5M | 0.32% | 66 |
|
|
2020
Q2 | $672M | Sell |
1,855,161
-45,351
| -2% | -$15.2M | 0.27% | 74 |
|
|
2020
Q1 | $539M | Buy |
1,900,512
+223,193
| +13% | +$70.4M | 0.26% | 81 |
|
|
2019
Q4 | $545M | Sell |
1,677,319
-144,937
| -8% | -$43.9M | 0.21% | 105 |
|
|
2019
Q3 | $531M | Sell |
1,822,256
-106,710
| -6% | -$30.6M | 0.21% | 96 |
|
|
2019
Q2 | $566M | Buy |
1,928,966
+1,911,308
| +10,824% | +$526M | 0.22% | 89 |
|
|
2019
Q1 | $4.83M | Sell |
17,658
-103
| -0.6% | -$25.6K | 0.03% | 514 |
|
|
2018
Q4 | $3.98M | Buy |
17,761
+207
| +1% | +$48.6K | 0.03% | 518 |
|
|
2018
Q3 | $4.29M | Sell |
17,554
-266
| -1% | -$61.2K | 0.02% | 531 |
|
|
2018
Q2 | $3.69M | Buy |
17,820
+539
| +3% | +$114K | 0.02% | 511 |
|
|
2018
Q1 | $3.57M | Sell |
17,281
-82
| -0.5% | -$17.2K | 0.02% | 513 |
|
|
2017
Q4 | $3.3M | Sell |
17,363
-14
| -0.1% | -$2.68K | 0.02% | 517 |
|
|
2017
Q3 | $3.29M | Sell |
17,377
-615
| -3% | -$111K | 0.02% | 539 |
|
|
2017
Q2 | $3.14M | Sell |
17,992
-10,323
| -36% | -$1.73M | 0.02% | 544 |
|
|
2017
Q1 | $4.35M | Sell |
28,315
-18,392
| -39% | -$2.81M | 0.03% | 532 |
|
|
2016
Q4 | $6.59M | Buy |
46,707
+12,752
| +38% | +$1.88M | 0.03% | 561 |
|
|
2016
Q3 | $5.4M | Sell |
33,955
-30,114
| -47% | -$4.64M | 0.03% | 515 |
|
|
2016
Q2 | $9.47M | Buy |
64,069
+29,735
| +87% | +$4.39M | 0.06% | 365 |
|
|
2016
Q1 | $4.86K | Buy |
34,334
+3,136
| +10% | +$420K | 0.03% | 485 |
|
|
2015
Q4 | $4.42K | Buy |
31,198
+788
| +3% | +$105K | 0.02% | 493 |
|
|
2015
Q3 | $3.72K | Sell |
30,410
-68
| -0.2% | -$8.86K | 0.02% | 569 |
|
|
2015
Q2 | $3.96K | Sell |
30,478
-842
| -3% | -$110K | 0.02% | 573 |
|
|
2015
Q1 | $4.21M | Sell |
31,320
-116
| -0.4% | -$15K | 0.02% | 565 |
|
|
2014
Q4 | $3.94M | Buy |
31,436
+3,808
| +14% | +$463K | 0.02% | 610 |
|
|
2014
Q3 | $3.36M | Buy |
27,628
+1,081
| +4% | +$131K | 0.02% | 642 |
|
|
2014
Q2 | $3.13M | Sell |
26,547
-1,073
| -4% | -$126K | 0.02% | 654 |
|
|
2014
Q1 | $3.32M | Buy |
27,620
+1,805
| +7% | +$215K | 0.02% | 629 |
|
|
2013
Q4 | $2.88M | Sell |
25,815
-3,303
| -11% | -$328K | 0.02% | 648 |
|
|
2013
Q3 | $2.68M | Sell |
29,118
-26,629
| -48% | -$2.41M | 0.02% | 690 |
|
|
2013
Q2 | $4.72M | Buy |
+55,747
| New | +$4.64M | 0.03% | 525 |
|
Other funds holding TMO
Nuveen's TMO Position: Q2 2026 in Review
Nuveen reduced its Thermo Fisher Scientific (TMO) stake by 8.1% in Q2 2026, selling an estimated $64.2M and leaving 1,513,180 shares worth $759M. The position accounts for 0.18% of the portfolio, ranked #100.
Nuveen first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.24B in Q4 2025. 2,602 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Nuveen held 1,513,180 shares of Thermo Fisher Scientific worth $759M as of Q2 2026.
- Nuveen sold 133,809 Thermo Fisher Scientific shares in Q2 2026, an estimated $64.2M.
- Thermo Fisher Scientific made up 0.18% of Nuveen's portfolio in Q2 2026, its #100 holding.
- Nuveen first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- Nuveen's Thermo Fisher Scientific position peaked at $1.24B in Q4 2025.
- 2,602 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.